Preferred Label : R-HyperCVAD Alternating with High-dose MTX AraC/Rituximab Regimen;
NCIt synonyms : R-hyperCVAD Alternating with R-Methotrexate-Cytarabine; Rituximab Plus HyperCVAD Alternating with Rituximab-Methotrexate/Cytarabine; Rituximab Plus Hyper-CVAD Alternating with R-Methotrexate/Cytarabine; R-HCVAD Plus Methotrexate/Cytarabine; R-HyperCVAD/MTX/AraC; Rituximab Plus HyperCVAD Alternating with Rituximab Plus High-dose Cytarabine and
Methotrexate; Rituximab Plus HyperCVAD Alternating with R-Methotrexate/Cytarabine; Rituximab-Hyperfractionated Cyclophosphamide-Vincristine-Adriamycin-Dexamethasone
Alternating with Rituximab/Cytarabine/Methotrexate; R-HyperCVAD/HD MTX AraC Regimen;
NCIt related terms : R-HyperCVAD Alternating with High-dose MTX AraC Regimen; R-Hyper-CVAD/R-MA;
NCIt definition : A regimen consisting of rituximab, cyclophosphamide, vincristine, doxorubicin and
dexamethasone, administered on a hyperfractionated schedule, and alternating with
rituximab, and high-dose methotrexate and cytarabine that can be used for the treatment
of mantle cell lymphoma (MCL), AIDS-related B-cell lymphomas, Burkitt lymphoma, chronic
lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL), diffuse large B-cell
lymphoma (DLBCL) and acute lymphoblastic leukemia (ALL), as well as other types of
lymphomas.;
NCI Metathesaurus CUI : CL538294;
Codes from synonyms : 4573;
Origin ID : C140115;
UMLS CUI : C4682710;
Semantic type(s)
- chemotherapy_regimen_has_component
- concept_is_in_subset
